Browse our available pharmaceutical and biotech manufacturing facilities
to find the perfect fit for your unique needs.

Featured Facility

Sellersville, PA

Oral Solids, Liquids, Creams and Ointments Manufacturing and Packaging

221,239 sq ft

PharmaBioSource Realty is exclusively representing G&W Laboratories to divest its oral solids, liquids, creams and ointments manufacturing and packaging operation.  The site is fully staffed and comes with a contract manufacturing supply agreement. IN DUE DILIGENCE

Available Facilities

Please find below a sampling of Biotechnology, Life Sciences, and Pharmaceutical Facilities we either represent or have knowledge of. If any particular facility is of interest to you or maybe you have more specific needs, please don’t hesitate to contact us at or phone us at 610.293.0900.

United States

Parenteral Fill / Finish Manufacturing

300,000 SF

Commercial-scale parenteral fill / finish manufacturing site with significant lyophilization capacity.  Includes trailing supply agreement.  IN DUE DILIGENCE.

Northeast U.S.

Solid Dosage Manufacturing and Development Facility

100,000 SF

Fully equipped and validated solid dosage development and manufacturing facility with fully fit-out R&D and analytical laboratories.

Elk Grove Village, Illinois

Small Molecule API Development and Manufacturing Facility

60,000 SF

Fully equipped, never used small molecule API pilot plant and manufacturing facility with spray drying capabilities located near Chicago.  OFF THE MARKET

Marketing Flyer

Deals We've Closed

Milford, MA

Biologics API Manufacturing

93,000 SF

PharmaBioSource Realty exclusively represented Shire to sell its Milford, MA roller bottle manufacturing facility to Rentschler Biopharma.

Press Release

Krems, Austria

Biologics / Vaccines Manufacturing

340,000 SF

Shire’s utility-ready biologics / vaccines manufacturing site acquired by Merck Animal Health.

Press Release

Hayward, CA

Biologics API Manufacturing

52,000 SF

Shire’s mammalian cell culture manufacturing facility with 3 x 2,000L single-use bioreactors acquired by Lonza Biologics.

Press Release

Andover, MA

API Development & Manufacturing

60,000 SF

Eisai’s 60,000 SF high potency small molecule API development and manufacturing facility sold to Sarepta Therapeutics.

Press Release

Brooklyn Park, MN

Biologics API Manufacturing

Baxalta’s mammalian cell culture biologics API manufacturing facility with 2 X 10,000L bioreactors sold to Takeda.

Commack, NY

Solid Dosage Development & Manufacturing

Actavis (former Forest Labs) 103,530 SF solid dosage development and manufacturing facility located on Long Island, NY sold to Ropack Pharma Solutions.

Hauppage, NY

Clinical Packaging

Actavis (former Forest Labs) 110,186 SF clinical packaging and warehouse facility located on Long Island, NY sold to Ropack Pharma Solutions.

Corona, CA

Solid Dosage Packaging

Actavis (former Watson Pharmaceuticals) 285,433 SF solid dosage packaging facility acquired by Bristol Youcare.

Corona, CA

Solid Dosage Manufacturing

Actavis (former Watson Pharmaceuticals) 196,613 SF solid dosage manufacturing facility acquired by Bristol Youcare.

Pearl River, NY

Vaccine Manufacturing

Leased 78,000 SF of Pfizer’s biologics manufacturing facility to Protein Sciences.

West Lebanon, NH

Biologics API Manufacturing

Olympus Biotech’s 180,000 SF mammaliam cell culture manufacturing facility sold to Novo Nordisk.

Bristol, TN

Solids and Semi-Solids Manufacturing

Sold Pfizer’s 400,000 SF oral and semi-solid dosage form manufacturing facility for tablets, capsules and creams / ointments with controlled substances capabilities to UPM Pharmaceuticals.

Caguas, Puerto Rico

Oral Dosage Manufacturing

475,000 SF Pfizer oral dosage manufacturing operation with high containment and controlled substances capabilities, contracts and staff sold to Neolpharma.

Brooklyn Park, MN

Biologics Manufacturing

Genmab’s 215,000 SF facility with 22,000L of mammalian cell culture capacity sold to Baxter Biosciences.

Rochester, MI

Parenteral Manufacturing

King Pharmaceuticals parenteral manufacturing business with 12 branded generic hospital products sold to JHP Pharmaceuticals.

Horsham, PA

Biologics Pilot Plant

Sold the Neose 50,000 SF GMP pilot plant with preclinical, Phase I and Phase II capability to 2,000L.

Morpeth, UK

API Manufacturing & Dosage Form

Pfizer’s 500,000 SF multi-product, multi-use development and manufacturing campus with staff and contracts sold to Nicholas Piramal.

Dorado, Puerto Rico

Solid Dosage Manufacturing

Sold Biovail’s 175,000 SF solid dosage manufacturing operation to Blu Pharmaceuticals.

Lakewood, NJ

Liquids & Creams Manufacturing

Subleased 221,000 SF of DPT Labs liquids and creams manufacturing facility to Accupac.

Carolina, Puerto Rico

Solid Dosage Manufacturing

Sold AstraZeneca’s 80,000 SF solid dosage manufacturing facility in Carolina, Puerto Rico.

Miami, FL

Sterile Manufacturing

Teva’s 90,000 SF sterile manufacturing facility with associated lab and warehouse acquired by Becton Dickinson.

Piscataway, NJ

Biologics R&D and Pilot Plant

Subleased 30,000 SF of Enzon’s biologics pilot plant and process development laboratories to Axcellerate Pharma.

Cambridge, MA

Biologics Development Labs

Leased 40,000 SF of Draper Labs biotech laboratories to Percivia, a joint venture between DSM and Crucell.

Gaithersburg, MD

Microbial Fermentation and Patch Manufacturing

Leased Intercell’s 54,000 SF microbial fermentation and patch manufacturing facility.

Devon, PA

R&D Laboratories

Nycomed’s 155,200 SF research lab facility with multi-function pilot plant sold to Merck Research Labs.

Success Stories


Representative Clients